Equillium Inc (NQ: EQ )
0.7990
+0.0690
(+9.45%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 14, 2024
Add to My Watchlist
All News about Equillium Inc
![](https://mms.businesswire.com/media/20230113005042/en/1685074/22/1_Equillium_Logo_400x400.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/27/image36.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221223005200/en/1672605/22/1_Equillium_Logo_400x400.jpg)
From Equillium, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221216005090/en/1667228/22/1_Equillium_Logo_400x400.jpg)
Equillium’s Partner Biocon Initiates Phase 2 Study of Itolizumab in Ulcerative Colitis
December 16, 2022
From Equillium, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/12/06/pipeline_bottom.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/07/image13.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221206005379/en/1655985/4/1_Equillium_Logo_400x400.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/02/screenshot_2022-12-02_at_7.22.16_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/aapharma_6.png?width=1200&height=800&fit=crop)
Equillium Shares Ride Higher After Positive Data From Lead Asset In Kidney Inflammation
September 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/07/aapharma.png?width=1200&height=800&fit=crop)
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
September 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22772.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221114005448/en/1322078/4/Equillium_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20221110005503/en/1322078/4/Equillium_Logo.jpg)
![](https://mms.businesswire.com/media/20221108005336/en/1322078/4/Equillium_Logo.jpg)
Equillium to Present at Two Upcoming Investor Conferences
November 08, 2022
From Equillium, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221103005508/en/1322078/4/Equillium_Logo.jpg)
Equillium Announces Presentation at the 6th Annual Dermatology Drug Development Summit
November 03, 2022
From Equillium, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221102005418/en/1322078/4/Equillium_Logo.jpg)
![](https://mms.businesswire.com/media/20221026005422/en/1322078/4/Equillium_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/image45.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17903.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/image-pepsico.png?width=1200&height=800&fit=crop)
This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology
September 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/27/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/27/21.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17854.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220927005571/en/1322078/4/Equillium_Logo.jpg)
![](https://mms.businesswire.com/media/20220915005475/en/1322078/4/Equillium_Logo.jpg)
From Equillium, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220906006103/en/824838/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20220906005973/en/1322078/4/Equillium_Logo.jpg)
Equillium to Acquire Metacrine in All-Stock Transaction
September 06, 2022
From Equillium, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220831005201/en/1322078/4/Equillium_Logo.jpg)
Equillium to Present at Two Upcoming Investor Conferences
August 31, 2022
From Equillium, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.